Hot Papers

D.A. Cheresh, J.W. Smith, H.M. Cooper, V. Quaranta, "A novel vitronectin receptor integrin (Aváx) is responsible for distinct adhesive properties of carcinoma cells," Cell, 57, 59-69, 7 April 1989. David A. Cheresh (Research Institute of Scripps Clinic, La Jolla, Calif.): "Cellular adhesion events are required for normal embryonic development, wound healing, thrombosis, and immune function. However, during disease processes (such as cancer, microbial infection, and inflammation), some of

| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

D.A. Cheresh, J.W. Smith, H.M. Cooper, V. Quaranta, "A novel vitronectin receptor integrin (Aváx) is responsible for distinct adhesive properties of carcinoma cells," Cell, 57, 59-69, 7 April 1989.

David A. Cheresh (Research Institute of Scripps Clinic, La Jolla, Calif.): "Cellular adhesion events are required for normal embryonic development, wound healing, thrombosis, and immune function. However, during disease processes (such as cancer, microbial infection, and inflammation), some of the same cellular adhesion mechanisms contribute to severe, and often fatal, consequences. During the last few years it has become clear that the molecular basis of these cellular adhesion mechanisms is determined to a large extent by a family of proteins termed integrins. The integrins are cell surface heterodimers that function in a cation-dependent manner.

"Our study was the first to demonstrate that within the integrin family of cell adhesion receptors a given A subunit (Av) could associate with more than one ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies